Skip to contentE
Endovia Health Sciences, Inc.
E
EDVAEndovia Health Sciences, Inc. Q3 2018 · 10-Q
Revenue$312.99K$312.99K−1.9% vs Q3 2017 Net Income-$4.99K-$4.99KN/M vs Q3 2017 EPS Diluted$0.00$0.00— vs Q3 2017 Gross Profit$165,077−3.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR
Operating Cash Flowderived$9,877−74.1% Free Cash Flowderived-$9,654N/M Margins · derivedGross margin52.7%−0.7 pt vs Q3 2017
Operating margin-0.7%−11.1 pt vs Q3 2017
Net margin-1.6%−12.7 pt vs Q3 2017
ended Sep 30, 2018 · filed Nov 14, 2018 · 45 d after period end